US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Partial Seizure - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Otitis Media - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Waldenstrom Macroglobulinemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cardiac Fibrosis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Cardiac Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cardiomyopathy - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Tinnitus - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Tinnitus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Acute Heart Failure - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Acute heart failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 190 largest Legionella Control (UK) companies. The Legionella Control (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... the 120 largest Biotechnology (UK) companies. The Biotechnology (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,520
Metastatic Melanoma - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Renal Cell Carcinoma - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Diabetic Nephropathy - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Diabetic Nephropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... And Neck Cancer Squamous Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Cognitive Impairment - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... therapeutic development for Cognitive Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Bipolar Disorder (Manic Depression), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019
9/30/2014 | published by: MarketsandMarkets
... and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput ...  |  read more...
USD 4,650
Irritable Bowel Syndrome - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Irritable Bowel Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Vitiligo - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
House Dust Mite Allergy - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for House Dust Mite Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Pulmonary Tuberculosis - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Post Menopausal Osteoporosis - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... information on the therapeutic development for Post Menopausal Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Hairy Cell Leukemia - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... information on the therapeutic development for Hairy Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10